Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports
-
- Oka Hideaki
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Homma Yoshito
- Department of Infectious Diseases, Ehime Prefectural Central Hospital, Japan
-
- Nishino Yuki
- Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University, Graduate School of Medicine, Japan
-
- Suemori Koichiro
- Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University, Graduate School of Medicine, Japan
-
- Sato Norio
- Department of Emergency and Critical Care Medicine, Ehime University, Graduate School of Medicine, Japan
-
- Sakurai Yuko
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Sekimoto Mizuki
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Ando Shota
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Iwamoto Saki
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Iwamoto Takaki
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Kondo Mika
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Kamimura Taro
- Division of Kidney Center, Matsuyama Red Cross Hospital, Japan
-
- Nakano Toshiaki
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan
-
- Kitazono Takanari
- Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan
この論文をさがす
説明
<p>A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 61 (12), 1869-1876, 2022-06-15
一般社団法人 日本内科学会